Little Green Pharma Ltd Asset Resilience Ratio
Little Green Pharma Ltd asset resilience ratio. Little Green Pharma Ltd (LGP) has an Asset Resilience Ratio of 2.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Little Green Pharma Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Little Green Pharma Ltd (2018–2025)
Asset resilience ratio of Little Green Pharma Ltd from 2018 to 2025. This chart shows how Little Green Pharma Ltd's Asset Resilience Ratio has changed over time. Read debt load of Little Green Pharma Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Little Green Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Little Green Pharma Ltd assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$2.30 Million | 2.36% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$2.30 Million | 2.36% |
Asset Resilience Insights
- Limited Liquidity: Little Green Pharma Ltd maintains only 2.36% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Little Green Pharma Ltd Industry Peers by Asset Resilience Ratio
Compare Little Green Pharma Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Little Green Pharma Ltd Asset Resilience Ratio by Year (2018–2025)
Little Green Pharma Ltd asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for Little Green Pharma Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 2.47% | AU$2.38 Million ≈ $1.68 Million |
AU$96.12 Million ≈ $68.01 Million |
-3.29pp |
| 2024-06-30 | 5.76% | AU$4.97 Million ≈ $3.52 Million |
AU$86.38 Million ≈ $61.12 Million |
-6.82pp |
| 2023-06-30 | 12.57% | AU$12.40 Million ≈ $8.77 Million |
AU$98.62 Million ≈ $69.78 Million |
-8.36pp |
| 2022-06-30 | 20.94% | AU$20.09 Million ≈ $14.21 Million |
AU$95.95 Million ≈ $67.89 Million |
-15.35pp |
| 2021-06-30 | 36.28% | AU$40.27 Million ≈ $28.49 Million |
AU$110.99 Million ≈ $78.53 Million |
+10.23pp |
| 2020-06-30 | 26.05% | AU$4.27 Million ≈ $3.02 Million |
AU$16.40 Million ≈ $11.61 Million |
+22.77pp |
| 2019-06-30 | 3.28% | AU$510.29K ≈ $361.06K |
AU$15.57 Million ≈ $11.01 Million |
-33.38pp |
| 2018-06-30 | 36.65% | AU$1.47 Million ≈ $1.04 Million |
AU$4.02 Million ≈ $2.85 Million |
-- |
About Little Green Pharma Ltd
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.